Braveheart Bio Bags $185M for Drug That Could Rival a Bristol Myers Squibb Cardio Med
Bristol Myers Squibb currently has the only drug approved specifically for treating obstructive hypertrophic cardiomyopathy, a debilitating disorder that can progress to heart failure. But safety risks and restrictions on this drug still leave an unmet …